Literature DB >> 32470389

Intensity of Renal Replacement Therapy and Duration of Mechanical Ventilation: Secondary Analysis of the Acute Renal Failure Trial Network Study.

Shilpa Sharma1, Yvelynne P Kelly2, Paul M Palevsky3, Sushrut S Waikar4.   

Abstract

BACKGROUND: Randomized clinical trials have failed to show benefit from increasing intensity of renal replacement therapy (RRT) for acute kidney injury, but continue to be frequently used. In addition, intensive RRT is associated with an increase in adverse events potentially secondary to small solute losses, such as phosphate. We hypothesized that, compared with less-intensive RRT, intensive RRT would lead to longer duration of mechanical ventilation. RESEARCH QUESTION: Does more-intensive renal replacement therapy in critically ill patients with acute kidney injury increase time to extubation from mechanical ventilation when compared with less-intensive therapy? STUDY DESIGN AND METHODS: The Acute Renal Failure Trial Network study was a randomized multicenter trial of more-intensive (hemodialysis or sustained low-efficiency dialysis six times per week or continuous venovenous hemodiafiltration at 35 mL/kg per hour) vs less-intensive (hemodialysis or sustained low-efficiency dialysis three times per week or continuous venovenous hemodiafiltration at 20 mL/kg per hour) RRT in critically ill patients with acute kidney injury. Of 1124 patients, 907 who were supported by mechanical ventilation on study initiation were included in this Cox-proportional hazards analysis. The primary outcome was the time to first successful extubation off mechanical ventilation.
RESULTS: Patients who were assigned randomly to more-intensive RRT had a 33.3% lower hazard rate of successful extubation (hazard ratio, 0.67; 95% CI, 0.52-0.88; P < .001) when compared with patients who were assigned to less-intensive RRT. Patients who were assigned to more-intensive RRT had, on average, 2.07 ventilator-free days, compared with 3.08 days in those who were assigned to less-intensive RRT (P < .001) over 14 days from start of the study.
INTERPRETATION: Critically ill mechanically ventilated patients who were assigned randomly to more-intensive RRT had longer duration of mechanical ventilation compared with those who were assigned to less-intensive RRT. The reasons for this, such as excessive phosphate loss from more-intensive RRT, deserve further study to optimize the safety and effectiveness of CRRT delivery. This was a post hoc analysis of the Acute Renal Failure Trial Network study; clinical trial registration of the original trial is NCT00076219. Published by Elsevier Inc.

Entities:  

Keywords:  acute kidney injury; critical care; mechanical ventilation; renal replacement therapy intensity

Mesh:

Year:  2020        PMID: 32470389      PMCID: PMC8173776          DOI: 10.1016/j.chest.2020.05.542

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  32 in total

1.  Management of renal replacement therapy in ICU patients: an international survey.

Authors:  Matthieu Legrand; Michael Darmon; Michael Joannidis; Didier Payen
Journal:  Intensive Care Med       Date:  2012-09-22       Impact factor: 17.440

2.  A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure.

Authors:  R L Mehta; B McDonald; F B Gabbai; M Pahl; M T Pascual; A Farkas; R M Kaplan
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

3.  Phosphate kinetics during different dialysis modalities.

Authors:  Ranistha Ratanarat; Alessandra Brendolan; Gopel Volker; Monica Bonello; Gabriella Salvatori; Emilio Andrikos; Asuman Yavuz; Carlo Crepaldi; Claudio Ronco
Journal:  Blood Purif       Date:  2005       Impact factor: 2.614

4.  Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial.

Authors:  Robert L Lins; Monique M Elseviers; Patricia Van der Niepen; Eric Hoste; Manu L Malbrain; Pierre Damas; Jacques Devriendt
Journal:  Nephrol Dial Transplant       Date:  2008-10-14       Impact factor: 5.992

5.  Higher renal replacement therapy dose delivery influences on drug therapy.

Authors:  Bruce A Mueller; Deborah A Pasko; Kevin M Sowinski
Journal:  Artif Organs       Date:  2003-09       Impact factor: 3.094

Review 6.  Complications of continuous renal replacement therapy.

Authors:  Kevin W Finkel; Amber S Podoll
Journal:  Semin Dial       Date:  2009 Mar-Apr       Impact factor: 3.455

7.  Intensity of renal support in critically ill patients with acute kidney injury.

Authors:  Paul M Palevsky; Jane Hongyuan Zhang; Theresa Z O'Connor; Glenn M Chertow; Susan T Crowley; Devasmita Choudhury; Kevin Finkel; John A Kellum; Emil Paganini; Roland M H Schein; Mark W Smith; Kathleen M Swanson; B Taylor Thompson; Anitha Vijayan; Suzanne Watnick; Robert A Star; Peter Peduzzi
Journal:  N Engl J Med       Date:  2008-05-20       Impact factor: 91.245

8.  Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy.

Authors:  M Broman; O Carlsson; H Friberg; A Wieslander; G Godaly
Journal:  Acta Anaesthesiol Scand       Date:  2010-10-29       Impact factor: 2.105

9.  Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.

Authors:  Santo Morabito; Valentina Pistolesi; Luigi Tritapepe; Elio Vitaliano; Laura Zeppilli; Francesca Polistena; Enrico Fiaccadori; Alessandro Pierucci
Journal:  BMC Nephrol       Date:  2013-10-25       Impact factor: 2.388

10.  Hypophosphatemia in critically ill patients with acute kidney injury treated with hemodialysis is associated with adverse events.

Authors:  Cynthia Lim; Han Khim Tan; Manish Kaushik
Journal:  Clin Kidney J       Date:  2017-01-05
View more
  5 in total

1.  Predictive validity of the quick Sequential Organ Failure Assessment (qSOFA) score for the mortality in patients with sepsis in Vietnamese intensive care units.

Authors:  Son Ngoc Do; Chinh Quoc Luong; My Ha Nguyen; Dung Thi Pham; Nga Thi Nguyen; Dai Quang Huynh; Quoc Trong Ai Hoang; Co Xuan Dao; Thang Dinh Vu; Ha Nhat Bui; Hung Tan Nguyen; Hai Bui Hoang; Thuy Thi Phuong Le; Lien Thi Bao Nguyen; Phuoc Thien Duong; Tuan Dang Nguyen; Vuong Hung Le; Giang Thi Tra Pham; Tam Van Bui; Giang Thi Huong Bui; Jason Phua; Andrew Li; Thao Thi Ngoc Pham; Chi Van Nguyen; Anh Dat Nguyen
Journal:  PLoS One       Date:  2022-10-14       Impact factor: 3.752

2.  Factors relating to mortality in septic patients in Vietnamese intensive care units from a subgroup analysis of MOSAICS II study.

Authors:  Son Ngoc Do; Chinh Quoc Luong; Dung Thi Pham; My Ha Nguyen; Nga Thi Nguyen; Dai Quang Huynh; Quoc Trong Ai Hoang; Co Xuan Dao; Trung Minh Le; Ha Nhat Bui; Hung Tan Nguyen; Hai Bui Hoang; Thuy Thi Phuong Le; Lien Thi Bao Nguyen; Phuoc Thien Duong; Tuan Dang Nguyen; Yen Hai Vu; Giang Thi Tra Pham; Tam Van Bui; Thao Thi Ngoc Pham; Hanh Trong Hoang; Cuong Van Bui; Nguyen Minh Nguyen; Giang Thi Huong Bui; Thang Dinh Vu; Nhan Duc Le; Trang Huyen Tran; Thang Quang Nguyen; Vuong Hung Le; Chi Van Nguyen; Bryan Francis McNally; Jason Phua; Anh Dat Nguyen
Journal:  Sci Rep       Date:  2021-09-23       Impact factor: 4.379

3.  Trends in Adaptive Design Methods in Dialysis Clinical Trials: A Systematic Review.

Authors:  Conor Judge; Robert Murphy; Catriona Reddin; Sarah Cormican; Andrew Smyth; Martin O'Halloran; Martin J O'Donnell
Journal:  Kidney Med       Date:  2021-08-20

4.  Hypophosphatemia on ICU Admission Is Associated with an Increased Length of Stay in the ICU and Time under Mechanical Ventilation.

Authors:  Hannah Wozniak; André Dos Santos Rocha; Tal Sarah Beckmann; Christophe Larpin; Niccolò Buetti; Hervé Quintard; Jérôme Pugin; Claudia Paula Heidegger
Journal:  J Clin Med       Date:  2022-01-24       Impact factor: 4.241

Review 5.  COVID-19 and AKI: Where Do We Stand?

Authors:  Paul M Palevsky
Journal:  J Am Soc Nephrol       Date:  2021-02-26       Impact factor: 10.121

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.